Jansen Aaltje P D, Muntinga Maaike E, Bosmans Judith E, Berghmans Bary, Dekker Janny, Hugtenburgh Jacqueline, Nijpels Giel, van Houten Paul, Laurant Miranda G H, van der Vaart Huub C H
Amsterdam Public Health research institute, VU University Medical Center, Amsterdam, The Netherlands.
Department of General Practice and Elderly Care Medicine, VU University Medical Center, Amsterdam, The Netherlands.
BMC Nurs. 2017 Feb 22;16:10. doi: 10.1186/s12912-017-0204-8. eCollection 2017.
Guidelines on urinary incontinence recommend that absorbent products are only used as a coping strategy pending definitive treatment, as an adjunct to ongoing therapy, or for long-term management after all treatment options have been explored. However, these criteria are rarely met and a significant share of long-term product users could still benefit from therapeutic interventions recommended in guidelines for urinary incontinence. Better implementation of these guidelines can potentially result in both health benefits for women and long-term cost savings for society. The aim of the COCON study is to evaluate the (cost-)effectiveness of a nurse-led intervention to optimise implementation of guideline-concordant continence care in comparison with usual care for urinary incontinent women aged 55 years and over who use absorbent products.
This randomised clinical trial compares usual care with a nurse-led intervention to optimise implementation of guideline-concordant continence care. Women (anticipated = 160) are recruited in 12 community pharmacies in three Dutch regions, and are eligible for trial entry when they are 55 years and over, community-dwelling and long-term users of absorbent products (≥4 months) reimbursed by health insurance. Measurements are administered at baseline, 3, 6 and 12 months. Primary outcome is severity of urinary incontinence (ICIQ-UI SF); other outcomes include health related quality of life (EQ-5D-5 L), use of absorbent products (in accordance with the recommended criteria in guidelines) (yes/no), and societal costs. Mixed model analysis will be performed to compare (the course) of outcomes between groups. The economic evaluation will be performed from a societal perspective. The implementation process is investigated using the Tailored Implementation for Chronic Diseases (TICD) framework.
Results will add to current knowledge of the (cost-)effectiveness of nurse-led primary healthcare to improve guideline-concordant care for older women with urinary incontinence. In addition, the results will provide more insight into care needs and health service utilization of this group of women, as well as into use of absorbent products in accordance with the recommended criteria in guidelines. Finally, results will increase our understanding of the intervention's uptake and could provide useful insights for future dissemination and sustenance.
Dutch Trial Register NTR4396, registered 13-January-2014.
尿失禁指南建议,吸收性产品仅应在等待确定性治疗期间作为应对策略使用,作为正在进行的治疗的辅助手段,或在探索了所有治疗方案后用于长期管理。然而,这些标准很少得到满足,相当一部分长期使用产品的用户仍可从尿失禁指南中推荐的治疗干预措施中获益。更好地实施这些指南可能会给女性带来健康益处,并为社会节省长期成本。COCON研究的目的是评估由护士主导的干预措施与常规护理相比,对55岁及以上使用吸收性产品的尿失禁女性优化实施符合指南的尿失禁护理的(成本)效益。
这项随机临床试验将常规护理与由护士主导的干预措施进行比较,以优化实施符合指南的尿失禁护理。在荷兰三个地区的12家社区药房招募女性(预计n = 160),年龄在55岁及以上、居住在社区且为吸收性产品的长期使用者(≥4个月)且由医疗保险报销的女性有资格进入试验。在基线、3个月、6个月和12个月进行测量。主要结局是尿失禁的严重程度(ICIQ-UI SF);其他结局包括健康相关生活质量(EQ-5D-5L)、吸收性产品的使用(符合指南中的推荐标准)(是/否)以及社会成本。将进行混合模型分析以比较两组之间的结局(过程)。经济评估将从社会角度进行。使用慢性病定制实施(TICD)框架对实施过程进行调查。
结果将增加目前关于由护士主导的初级医疗保健对改善老年尿失禁女性符合指南护理的(成本)效益的知识。此外,结果将更深入地了解该组女性的护理需求和卫生服务利用情况,以及按照指南推荐标准使用吸收性产品的情况。最后,结果将增进我们对干预措施采用情况的理解,并可为未来的传播和维持提供有用的见解。
荷兰试验注册中心NTR4396,于2014年1月13日注册。